A Phase 2 study is expected to enroll up to 20 children ages 2–18, with dosing targeted for Q1 2027; mecasermin is not ...

After regulatory approval, Broadridge's services will link proxy materials and voting rules, and let NYSE-listed issuers ...

Adjusted EBITDA rose 19% to $10 million, above guidance. ISG targets fourth-quarter revenue of $64 million to $65 million and ...

Results are scheduled for about 6:50 a.m. ET, followed by management’s live call at about 8:30 a.m.; an archived version will ...

Mark O’Shea will discuss automation and adhesives for medical sensor production on Nov. 18; both technologies are slated for ...

The agreements cover new New Mexico acreage and extend Black River service. Matador expects 2026 midstream spending to rise ...

Gabar has produced more than 50 million barrels since 2021; the minister put its economic contribution at about US$3.5 ...

As of Sept. 30, Sinda had $305.6 million in cash and equivalents; it plans 122,000 meters of Phase 2 drilling, with site ...

Permits for a construction decision are expected as early as 2028; commercial operations at Fenn-Gib could begin as early as ...

Recent: BRS Resources Approved to Commence Trading on the OTCQB Venture Market. Track all BSREF press releases, SEC filings, ...

LXP shareholders will receive $61.20 per share in cash; its shares no longer trade on the NYSE, and LXP is now a privately ...

Immunic (Nasdaq: IMUX) will participate in three investor conferences during November 2026, with fireside chats and ...